Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Regulatory explorer
Regulatory document

FDA Proposed Rule on Front-of-Package Nutrition Information: Comment Period Extended

The FDA, part of the US Health and Human Services Department, extended the comment period for its January 16, 2025 proposed rule on front-of-package nutrition information, responding to requests for more time to submit comments. This is a proposed rule, not a final rule. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The FDA extended the comment period for its January 16, 2025 proposed rule on front-of-package nutrition information. [1]

  2. The extension responds to requests for additional time to submit comments. [1]

  3. A proposed rule or notice is not a final rule, and a publication date is not necessarily an effective date. [1]

The source at a glance

Jurisdiction
US
Authority
Health and Human Services Department; Food and Drug Administration
Document type
Proposed Rule
Record type / format
Proposed Rule (Federal Register document record)
Scope / context
US food labeling; the documented subject is the comment period for the front-of-package nutrition information proposed rule.
Summary based on
Official regulatory document
Original publication
May 9, 2025

US FDA proposed rule and its comment extension

This is a Federal Register record from the US Food and Drug Administration, part of the Health and Human Services Department. The document type is a proposed rule. It concerns food labeling, specifically front-of-package nutrition information. The agency states it is extending the comment period for the proposed rule that appeared in the Federal Register on January 16, 2025. The stated reason is requests for an extension so interested parties have additional time to submit comments.

Supporting source [1]

What the supplied record explicitly covers

The supplied text is the agency abstract and metadata, not the full document. It identifies the agency, jurisdiction (United States), document type (proposed rule) and publication date of May 9, 2025. It describes only the extension of the comment period and the reason given. It does not describe the content of the underlying nutrition-labeling proposal, any requirements, or any compliance obligations.

Supporting source [1]

Status, official edition and date caveats

The record states that a proposed rule or notice is not a final rule, and that a publication date is not necessarily an effective date. The web/API rendition is described as an informational resource, not the official legal edition; readers are directed to verify the linked official PDF on GovInfo and any later amendments. The source alone does not determine a product's compliance or current legal status.

Supporting source [1]

How to interpret this

Document summary; not a determination of current law. Based only on the agency abstract and metadata; the full document was not reviewed. The web/API rendition is informational, not the official legal edition.

Based on the cited official document. Its jurisdiction, document type and effective date matter; a proposal or notice is not a rule already in force.

Source & supporting passages

[1]
Food Labeling: Front-of-Package Nutrition Information; Extension of Comment Period

Health and Human Services Department; Food and Drug Administration · federalregister.gov · May 9, 2025

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    extending the comment period for the proposed
  2. Finding 2 ↑

    in response to requests for an extension
  3. Finding 3 ↑

    A proposed rule or notice is not

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…